Name | Garazhno-stroitel'nyy kooperativ "ZORGE 7" |
|---|
INN | 7714192420 |
|---|
KPP | 771401001 |
|---|
OGRN | 1027739252310 |
|---|
OKPO | 55237918 |
|---|
Address | 123308, G.moskva, ul. Zorge, d. D.7A |
|---|
Phone | 195-97-86 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 52.21.24 | Core activity | Activities of Parking for vehicles |
Registration date | 25.09.2002 |
|---|
Registering department | MEZHRAYONNAYA INSPEKTSIYA MNS ROSSII N 39 PO G.MOSKVE |
|---|
|
GSK "ZORGE 7" (Moscow; INN 7714192420) was registered on 25 Sep 2002. The company's authorized capital as of July 1, 2012 was 15 rub. Type of ownership of GSK "ZORGE 7" - Comsumer cooperatives. Form of ownership of GSK "ZORGE 7" - Private property. Principal activities of GSK "ZORGE 7": activities of parking for vehicles (52.21.24). |
Economic indicators2023
Net loss (RA) of GSK ZORGE 7 made up 2.87 million RUB over 2023 compared to net profit of 916.00 thousand RUB over 2022, the company informed. Revenue decreased in the accounting period by 8.70% to 9.12 million RUB from 9.99 million RUB in 2022; sales loss made up 3.02 million RUB compared to sales profit of 923.00 thousand RUB. 2022
Net profit (RAS) of GSK ZORGE 7 over 2022 was the same as in 2021 reaching 916.00 thousand RUB, the company informed. Revenue remained in the accounting period at the same level and made up 9.99 million RUB compared to 9.99 million RUB 9.99 million RUB; sales profit matched the previous year’s result amounting to 923.00 thousand RUB. 2021
Net profit (RAS) of Garazhno-stroitel'nyy kooperativ ZORGE 7 over 2021 was the same as in 2020 reaching 916.00 thousand RUB, the company informed. Revenue remained in the accounting period at the same level and made up 9.99 million RUB compared to 9.99 million RUB 9.99 million RUB; sales profit matched the previous year’s result amounting to 923.00 thousand RUB. 2020
Net profit (RAS) of GSK ZORGE 7 dropped in 2020 3.16 times to 916.00 thousand RUB from 2.89 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 28.60% to 9.99 million RUB from 14.00 million RUB in 2019; sales profit fell 3.06 times to 923.00 thousand RUB from 2.83 million RUB. 2019
Net profit (RAS) of GSK ZORGE 7 grew over 2019 by 43.22% to 2.89 million RUB from 2.02 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 1.25% to 14.00 million RUB from 14.17 million RUB in 2018; sales profit fell by 7.04% to 2.83 million RUB from 3.04 million RUB. 2018
Net profit (RAS) of GSK ZORGE 7 grew over 2018 37.41 times to 2.02 million RUB from 54.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 22.51% to 14.17 million RUB from 11.57 million RUB over 2017; sales profit went up 10.10 times to 3.04 million RUB from 301.00 thousand RUB. 2017
Net profit (RAS) of GSK ZORGE 7 made up 54.00 thousand RUB over 2017 compared to net loss of 8.28 million RUB over 2016, the company informed. Revenue increased in the accounting period by 40.73% to 11.57 million RUB from 8.22 million RUB over 2016; sales profit made up 301.00 thousand RUB compared to sales loss of 7.97 million RUB. 2016
Net profit (RAS) of GSK ZORGE 7 made up 2.84 million RUB over 2016 compared to net loss of 308.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 25.29% to 11.75 million RUB from 9.38 million RUB over 2015; sales profit made up 3.03 million RUB compared to sales loss of 30.00 thousand RUB. 2014
2013
Net loss (RAS) of GSK Zorge 7 increased 3.01 times to 1.04 million RUB from 346.32 thousand RUB over 2012, the company informed.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|